Drugs / DD-S052P
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07347223 | Jul 2023 → May 2025 | — | HLB Science | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DD-S052P | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07347223 ↗ |
| Route | Intravenous | “administered as an intravenous infusion” NCT07347223 ↗ |